2021 annual financial data
Fate Therapeutics 2021 Operating cash flow margin
Fate Therapeutics 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -291.64%.
Operating income was -216,994,000 USD and net income was -212,151,000 USD.
Operating cash flow was -162,870,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,846,000 USD
- Operating income
- -216,994,000 USD
- Net income
- -212,151,000 USD
- Operating cash flow
- -162,870,000 USD